As the Trump administration enters its second year with a focus on affordability, investors must consider what the president’s latest policies will mean for markets.
Insights
Our latest thinking on the themes shaping today’s investment landscape. Explore timely updates, quarterly features and in-depth analysis straight from our experts.
Assessing the potential impact of President Trump’s “most favored nation” drug pricing policy on biopharma companies.
The two West African nations are in the midst of tectonic political and economic shifts. How likely are they to succeed?
Jenna Barnard believes political upheaval may lean in favour of bonds.